PEPTIDE_CODEX

← All peptides

PC-012 · nootropic · semax

Semax

ACTH 4-10 analogue

Also: Heptapeptide

Met-Glu-His-Phe-Pro-Gly-Pro

human trialanimal study

A synthetic analogue of ACTH (adrenocorticotropic hormone) fragment 4-10, developed in Russia and approved there as a nootropic drug. Semax enhances memory, attention, and cognitive function without hormonal side effects. It's been used clinically for stroke recovery and cognitive impairment.

Increases BDNF and NGF expression, modulates dopaminergic and serotonergic neurotransmission, enhances neuronal survival and plasticity. Unlike full ACTH, Semax lacks steroidogenic activity — it only retains the nootropic/neuroprotective fragment.

  • Cognitive enhancement
  • Memory improvement
  • Stroke recovery
  • ADHD symptoms
  • Neuroprotection
  • · Nasal irritation
  • · Headache (rare)
  • · Hair loss (very rare, anecdotal)

Mechanism of Action

Increases BDNF and NGF expression, modulates dopaminergic and serotonergic neurotransmission, enhances neuronal survival and plasticity. Unlike full ACTH, Semax lacks steroidogenic activity — it only retains the nootropic/neuroprotective fragment.

Common Uses

Cognitive enhancementMemory improvementStroke recoveryADHD symptomsNeuroprotection

Dosage & Pharmacology

DOSAGE RANGE: 200-600 mcg 2-3x daily (intranasal)
HALF-LIFE: ~2-3 minutes (but neurotrophic effects persist 20-24 hours)
MOL. WEIGHT: 813.93 Da
SEQUENCE:
Met-Glu-His-Phe-Pro-Gly-Pro
Dosage information is for research reference only. Not a recommendation.

Known Side Effects

  • Nasal irritation
  • Headache (rare)
  • Hair loss (very rare, anecdotal)

Legal Status

US:Not FDA-approved, research chemical
UK:Not approved
EU:Not approved
RU:Approved medication

Related Peptides

View all Semax research on PubMed